Calcimimetic and vitamin D receptor agonist therapy associates with lower mortality and fractures in hemodialysis patients: an international DOPPS analysis.

Clin Kidney J · 2026 · PMC13329188 · PMID 42404077

Europe PMC DOI

hedged sentence

0.0820

closest p · 1.6× alpha

0.0820

boldest claim

The sentences

a nonsignificant trendP = .082so close (0.05 < p ≤ 0.1)

Calcimimetics-only use showed a nonsignificant trend toward lower hip fracture risk (HR 0.67, 95% CI 0.43–1.05; P = .082).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.